Nuvation Bio Inc. Class A Common Stock vs PPL Corporation Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while PPL Corporation Common Stock trades at $34.08 (market cap $25.55B). The key difference: PPL Corporation Common Stock is far larger — about 14.9× Nuvation Bio Inc. Class A Common Stock's market cap, and PPL Corporation Common Stock pays a 3.36% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and PPL Corporation Common Stock for 0 Days on average.
| NUVB | PPL | |
|---|---|---|
Market Cap | $1.71B | $25.55B |
Volume | 5,448,712 | 6,874,595 |
Sector | Health | Utilities |
52-Week High | $9.54 | $39.81 |
52-Week Low | $3.41 | $31.97 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.30B | $45.54B |
Dividend Yield | — | 3.36% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →PPL Corporation is a regulated utility holding company. Through its subsidiaries, it generates, transmits, distributes, and sells electricity and natural gas in Kentucky, Pennsylvania, and Rhode Island.
Read more on PPL →